Видео с ютуба Imfinzi

FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung Cancer

Durvalumab - Imfinzi - All You Need to Know in 2 Minutes.

Durvalumab ( Imfinzi ) for HCC

Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - Lung Cancer

Imfinzi (durvalumab) plus bevacizumab met endpoints in EMERALD-1 Phase III results in Liver Cancer

Mickey and his caregiver, Carla, talk about IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl)

Durvalumab (Imfinzi): How It Works, Benefits, and Side Effects Explained

Durvalumab / Imfinzi (NIAGRA Trial) Defies Odds in MIBC Survival Benefits Beyond Complete Response

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care? (BMIC-024)

Trending in Oncology: Imfinzi Fast Track, Ivonescimab Milestone and more

Imfinzi Uses: Guide to Understanding the Many Benefits of this Breakthrough Immunotherapy

MOA of IMFINZI in 1L mNSCLC - Narrated by Debbie Irwin

Lung Cancer Video Library - Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

Groundbreaking Cancer Treatment: IMFINZI® Reduces Cancer Recurrence and Death Rates AstraZeneca News

OncTalk 2021 - PDL1 and Imfinzi/Durvalumab

AstraZeneca - IMFINZI Launch

The impact of durvalumab on the SCLC treatment landscape

FDA Prioritizes AstraZeneca’s Imfinzi for Small Cell Lung Cancer Patients

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers

5-year OS results of HIMALAYA: durvalumab + tremelimumab in unresectable hepatocellular carcinoma

FDA D.I.S.C.O. Burst Edition: FDA approval of Imfinzi (durvalumab) for adult patients with locall...

ASCO 2018 - Dream Study - Chemo with Imfinzi (durvalumab) for Mesothelioma